基于纳米技术的疟疾药物输送系统
Sedanur Keleş1, Jahid Alakbarli2, Buşra Akgül3
1Faculty of Engineering, Department of Metallurgical and Materials Engineering, Karadeniz Technical University, Trabzon, Turkey.
International journal of pharmaceutics
|September 25, 2024
概括
纳米技术通过改善药物输送,为疟疾治疗提供了新的希望. 纳米载体系统提高了抗疟疾药物的有效性,控制了释放,并减少了副作用,解决了传统疗法的局限性.
科学领域:
- 医学昆虫学 医学昆虫学
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 疟疾是由安诺菲莱斯蚊子传播的虫寄生虫引起的,是全球重要的健康问题,特别是在热带地区.
- 疟原 (Plasmodium falciparum) 和疟原 (Plasmodium vivax) 是最致命的疟疾物种,对人类健康构成重大风险.
- 传统的抗疟疾药物面临毒性和生物分布不良等挑战,需要改进治疗策略.
研究的目的:
- 审查疟疾治疗药物输送系统的进展,重点关注聚合物和脂质基纳米粒子.
- 为疟疾治疗纳米技术的最新发展提供全面的概述.
- 突出纳米载体在克服传统抗疟疾药物的局限性方面的作用.
主要方法:
- 关于用于治疗疟疾的纳米载体系统的最新文献的综述.
- 对各种纳米载体类型的检查,包括聚合物纳米囊,树枝状体,菌体,脂质体,脂质纳米颗粒,体和外体.
- 讨论当前的抗疟疾治疗策略和世界卫生组织的建议.
主要成果:
- 纳米载体系统在提高抗疟疾药物的有效性和控制药物释放方面表现有前途.
- 这些系统可以改善药物的生物分布,并最大限度地减少与传统抗疟疾药物相关的不良影响.
- 目前正在探索各种纳米载体平台,以有针对性地传递和改善抗疟疾药物的药理资料.
结论:
- 纳米技术,特别是纳米载体系统,代表了疟疾治疗策略的重大进步.
- 纳米载体为抗疟疾药物提供了改进的向药物递送,可控释放和增强的药理特性.
- 基于纳米载体的疟疾治疗方法的进一步研究和开发有可能在疾病管理方面取得未来的突破.
更多相关视频
05:28Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
2.9K
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.3K
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...